The Association of IL-6, TNFα and CRP Gene Polymorphisms with Coronary Artery Disease in a Tunisian Population: A

Nedra Grira1,2, Dhaker Lahidheb3,4, Oussama Lamine3,5

  • 1Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia. nedra.grira@fst.utm.tn.

Biochemical Genetics
|February 2, 2021
PubMed

Insights

Genetic variations in Interleukin-6 (IL-6), Tumor Necrosis Factor alpha (TNFα), and C-reactive protein (CRP) genes are associated with increased coronary artery disease (CAD) risk in the Tunisian population. These polymorphisms may serve as crucial susceptibility markers for CAD.

Area of Science:

  • Cardiovascular Genetics
  • Immunology
  • Population Health

Background:

  • Coronary artery disease (CAD) is recognized as an inflammatory condition.
  • Systemic inflammation markers like Interleukin-6 (IL-6), Tumor Necrosis Factor alpha (TNFα), and C-reactive protein (CRP) are linked to cardiovascular event risk.
  • Investigating genetic susceptibility markers for CAD is crucial for understanding disease etiology.

Purpose of the Study:

  • To evaluate the association of specific gene variants (IL-6 -174 G/C, TNFα -308 A/G, CRP +1059G/C) with CAD susceptibility in a Tunisian cohort.
  • To determine if these polymorphisms act as risk factors for developing coronary artery disease.

Main Methods:

  • A case-control study was conducted with 204 CAD patients and 400 controls from Tunisia.
  • Genotyping of IL-6, TNFα, and CRP gene variants was performed using polymerase chain reaction and restriction fragment length polymorphism analysis.
  • Clinical data including BMI, smoking history, lipid profiles, and inflammatory marker levels were analyzed.

Main Results:

  • Significant differences in BMI, family history of CAD, smoking, TC, LDLc, hs-CRP, IL6, and TNFα levels were observed between CAD patients and controls.
  • Specific genotypes showed significant differences: IL6-174CC (OR=7.71), TNFα -308 AA (OR=2.95), and CRP +1059 CC (OR=5.40) were associated with increased CAD risk.
  • No association was found between these genotypes and the measured levels of inflammatory markers.

Conclusions:

  • The IL-6 (-174 G/C), TNFα (-308 A/G), and CRP (+1059G/C) polymorphisms are identified as potential risk factors for coronary artery disease in the Tunisian population.
  • These genetic variations may contribute to CAD susceptibility independent of their direct impact on circulating inflammatory marker levels.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.3K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
338
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.7K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
154
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
295
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
663